Gyeonggi, South Korea

Seung M Lee

This inventor holds 1 USPTO granted patent. Top assignee: Il-Yang Pharm. Co., Ltd. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seung M Lee. Retrieved from https://idiyas.com/inventor/seung-m-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seung M Lee: Innovator in Pharmaceutical Chemistry

Introduction

Seung M Lee is a notable inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on novel compounds.

Latest Patents

One of his key patents is for the compound 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinylbenzimidazole derivatives. This invention relates to a novel compound that has the potential for pharmaceutical applications. The compound is represented by the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof, where X can be S, SO, or SO₂. This patent showcases his expertise in developing new chemical entities that may have therapeutic benefits.

Career Highlights

Seung M Lee is associated with Il-Yang Pharm. Co., Ltd., where he has been instrumental in advancing research and development efforts. His work has contributed to the company's reputation in the pharmaceutical industry, particularly in the area of innovative drug development.

Collaborations

Throughout his career, Seung M Lee has collaborated with talented individuals such as Dong Young Kim and Sung June Park. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Seung M Lee is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative spirit and collaborative efforts continue to inspire progress in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…